CORNING LUKE received a stock award from POSEIDA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/16/2023ACC: 0000950170-23-028598
+47K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
47K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+19.65K
Price / share
—
Trade value
—
% of position
100.0%
6/15/2023
19.65K→39.30K
Total
Net shares
+19.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/15/2023 | A · Award | +19.65K | — | — | 100.0% | 19.65K | 39.30K |
| Total | +19.65K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
27.35K shares
Shares
+27.35K
Strike price
2.47
Held after
27.35K
Exercisable
—
6/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock27.35K shares | 6/15/2023 | A · Award | +27.35K | 2.47 | — | 27.35K |